Amy K. Fisher is a partner in the Drug and Device and Product Liability Litigation Groups, concentrating on national and local defense of complex, multidistrict litigation for pharmaceutical, chemical, device and cosmetic manufacturers in federal and state courts. Her practice also includes general products liability, toxic tort, medical malpractice, and contract defense. She has appeared before the Judicial Panel on Multidistrict Litigation on multiple occasions on behalf of numerous clients to address the merits of centralization.
Amy's practice is focused on product liability litigation, specifically the defense of pharmaceutical, chemical, device, and cosmetic manufacturers. She serves as national and local counsel on behalf of pharmaceutical, device and cosmetic companies for litigation involving a variety of prescription pharmaceuticals, cosmetics and medical devices. Amy oversees the defense of a number of complex, national litigations involving mass-tort product liability claims and is a member of multiple other national defense teams for nation-wide multidistrict litigation involving prescription pharmaceuticals manufactured by various companies. She also serves as local defense counsel for a number of other matters.
Amy has appeared at hearings before the Judicial Panel on Multidistrict Litigation on numerous occasions to address the merits of centralization of various litigations. She has significant experience with and familiarity of the JPML rules and procedures. Amy has a broad expertise, both at the state and federal levels, with unique removal, product identification and other creative initial dispositive motions, forum non conveniens, consolidation, summary judgment, and Daubert issues, and trials involving multiple plaintiffs. She is responsible for managing overall strategy, day-to-day coordination, and the complex discovery issues these cases pose for a number of national litigations, including a pharmaceutical multidistrict litigation in which nearly two thousand lawsuits were disposed of through creative and bifurcated case management and dispositive motions. Her practice includes consistent dealings with the Judicial Panel on Multidistrict Litigation and various MDLs, which often pose complex choice of law issues. She has experience taking and defending expert witness depositions.
Amy has also represented a variety of hospitals and health care providers in state and federal courts. She has both jury and bench trial experience.
She has participated in national seminars on the defense of drug and device manufacturers. In October 2010, Amy published an article entitled "What Happened to Rule 11? Baseless Pleadings and Product Identification" for the Defense Research Institute's monthly For the Defense publication and has co-authored another article for the Defense Research Institute titled, "The Importance of Post-Marketing Safety Surveillance in Product Liability Litigation: Issues and Developments." She has also spoken at a number of seminars on topics regarding medical malpractice and other health law issues.
Born in Indianapolis, Amy received her Bachelor of Arts from the University of Notre Dame. She earned her juris doctorate from the Indiana University School of Law-Indianapolis.
She joined Ice Miller LLP in August 2001. She is admitted to practice law in the state of Indiana and before the Ninth Circuit Court of Appeals. She is actively involved in various community organizations and with her family, including her husband and two sons.
Ice Miller News
"What Happened to Rule 11? Baseless Pleadings and Product Identification." Defense Research Institute, For the Defense (October 2010)
Presented on the panel "Developing a Game Plan for a Successful MDL Practice," at the 2016 International Association of Defense Counsel Annual Meeting